Equity Profile

PEN

Penumbra, Inc.

Health CareHealth Care Equipment$12.6B

May6Wed

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

Penumbra, Inc. Misses on EPS, Stock Up 0.1%

Metric	Actual	Expected	Surprise
EPS	$0.82	$1.06	-25.93%
Revenue	—	$372M	—

management commentary, guidance changes, and full analysis available with Pro.

Penumbra, Inc. Misses on EPS, Stock Up 0.1%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.82	$1.06	-25.93%
Revenue	—	$372M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Penumbra, Inc. reported earnings that fell short of expectations, particularly in EPS, which may raise concerns among investors. Despite the earnings miss, the stock saw a slight increase of 0.1%, indicating that investors may be taking a wait-and-see approach. The lack of revenue data and management commentary leaves uncertainty about the company's performance and future outlook.

Company Snapshot

Penumbra, Inc. is a healthcare company that develops innovative medical devices for treating vascular and neurovascular conditions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.06

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market presence and invest in future innovations.

$372M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Penumbra, Inc. is a healthcare company that develops innovative medical devices for treating vascular and neurovascular conditions. With a market cap of $13 billion, it plays a significant role in the health care equipment sector, focusing on improving patient outcomes through advanced technology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+7.72%

Avg Stock Reaction

-0.78%

Last Quarter Recap

In Q4 2025, Penumbra reported an EPS of $1.18, exceeding expectations by 5.36%. However, the stock experienced a slight decline of 0.27% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Penumbra to report solid earnings this quarter, with a consensus EPS of $1.06 and revenue of $372 million. The company has a strong track record of beating EPS estimates, which could influence investor sentiment.

Bull Case

If Penumbra exceeds EPS and revenue expectations, it could signal strong demand for its products and lead to increased investor confidence, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and market competition, leading to a negative reaction in the stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.06

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$372M

Revenue growth is crucial for assessing the company's ability to expand its market presence and invest in future innovations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.06?

A beat on EPS could reinforce investor confidence in Penumbra's growth and operational efficiency.

What is the revenue outlook compared to the consensus of $372 million?

Revenue performance is critical for understanding the company's market demand and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

While the consensus expects steady growth, there may be underappreciated risks related to market competition and product adoption rates that could lead to a disappointing quarter.

Supporting Evidence

The stock has historically reacted negatively even after earnings beats, suggesting that expectations may be overly optimistic.

Options pricing indicates a higher expected move than historical averages, hinting at potential volatility that the market may not fully anticipate.

Key Risk

If revenue growth shows signs of slowing or if competitive pressures are highlighted in the earnings call, it could significantly challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's ability to sustain growth amid competitive pressures.

Bull Confirmed If

An EPS of $1.10 or higher, along with revenue exceeding $375 million, would confirm the bull case.

Bear Confirmed If

An EPS below $1.00 or revenue falling short of $365 million would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.4%

Pricing rich

The options market is pricing in a modest move of about 2.09%, suggesting that investors are anticipating some volatility around the earnings report.

Options are pricing ±2.1% while PEN has averaged ±1.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.2%

30d HV

10.1%

Calls (2K)P/C Ratio: 2.50Puts (19K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Penumbra beats expectations, history suggests a potential average one-day move of +2.12%, confirming strong demand for its products.

In-Line / Cautious

Should the results come in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average one-day move of -0.77%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market competition and how it affects pricing strategies.
3Insights into customer adoption rates for recent innovations.
4Guidance on future revenue growth and any changes to market forecasts.
5Details on operational efficiencies and cost management strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Penumbra, Inc. is a healthcare company that develops innovative medical devices for treating vascular and neurovascular conditions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.06

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market presence and invest in future innovations.

$372M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+7.72%

Avg Stock Reaction

-0.78%

Last Quarter Recap

In Q4 2025, Penumbra reported an EPS of $1.18, exceeding expectations by 5.36%. However, the stock experienced a slight decline of 0.27% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Penumbra exceeds EPS and revenue expectations, it could signal strong demand for its products and lead to increased investor confidence, potentially driving the stock higher.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and market competition, leading to a negative reaction in the stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.06

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$372M

Revenue growth is crucial for assessing the company's ability to expand its market presence and invest in future innovations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.06?

A beat on EPS could reinforce investor confidence in Penumbra's growth and operational efficiency.

What is the revenue outlook compared to the consensus of $372 million?

Revenue performance is critical for understanding the company's market demand and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

While the consensus expects steady growth, there may be underappreciated risks related to market competition and product adoption rates that could lead to a disappointing quarter.

Supporting Evidence

The stock has historically reacted negatively even after earnings beats, suggesting that expectations may be overly optimistic.

Options pricing indicates a higher expected move than historical averages, hinting at potential volatility that the market may not fully anticipate.

Key Risk

If revenue growth shows signs of slowing or if competitive pressures are highlighted in the earnings call, it could significantly challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect the company's ability to sustain growth amid competitive pressures.

Bull Confirmed If

An EPS of $1.10 or higher, along with revenue exceeding $375 million, would confirm the bull case.

Bear Confirmed If

An EPS below $1.00 or revenue falling short of $365 million would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.4%

Pricing rich

The options market is pricing in a modest move of about 2.09%, suggesting that investors are anticipating some volatility around the earnings report.

Options are pricing ±2.1% while PEN has averaged ±1.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.2%

30d HV

10.1%

Calls (2K)P/C Ratio: 2.50Puts (19K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Penumbra beats expectations, history suggests a potential average one-day move of +2.12%, confirming strong demand for its products.

In-Line / Cautious

Should the results come in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average one-day move of -0.77%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market competition and how it affects pricing strategies.
3Insights into customer adoption rates for recent innovations.
4Guidance on future revenue growth and any changes to market forecasts.
5Details on operational efficiencies and cost management strategies.